期刊文献+

MicroRNAs与乳腺癌 被引量:2

下载PDF
导出
机构地区 安徽医科大学
出处 《山东医药》 CAS 北大核心 2010年第24期109-110,共2页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30873047) 安徽高校省级自然科学研究重点项目(KJ2009A162)
  • 相关文献

参考文献15

  • 1Kim VN,Han J,Siomi MC.Biogenesis of small RNAs in animals[J].Nat Rev Mol Cell Biol,2009,10(2):126-139.
  • 2Liu X,Fortin K,Mourelatos Z.MicroRNAs:Biogenesis and molecular functions[J].Brain Pathol,2008,18(1):113-121.
  • 3Nilsen TW.Mechanisms of microRNA-mediated gene regulation in animal cells[J].Trends Genet,2007,23(5):243-249.
  • 4Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 5Yu F,Yao H,Zhu P,et al.let-7 regulates self renewal and tumorigenicity of breast cancer cells[J].Cell,2007,131(6):1109-1123.
  • 6Scott GK,Goga A,Bhaumik D,et al.Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b[J].J Biol Chem,2007,282(2):1479-1486.
  • 7Shuomin Zhu,Hailong Wu,Fangting Wu,Daotai Nie,Shijie Sheng,Yin-Yuan Mo.MicroRNA-21 targets tumor suppressor genes in invasion and metastasis[J].Cell Research,2008,18(3):350-359. 被引量:208
  • 8Hossain A,Kuo MT,Saunders GF.Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA[J].Mol Cell Biol,2006,26 (21):8191-8201.
  • 9Gregory PA,Bert AG,Paterson EL,et al.The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1[J].Nat Cell Biol,2008,10(5):593-601.
  • 10Sempere LF,Christensen M,Silahtaroglu A,et al.Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer[J].Cancer Res,2007,67(24):11612-11620.

二级参考文献51

  • 1Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11:1753-1761.
  • 2Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309:1519-1524.
  • 3Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
  • 4Fitzgerald K. RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes. Curr Opin Drug Discov Dev 2005, 8:557-566.
  • 5Brennecke J, Stark A, Russell R.B, Cohen SM. Principles of microRNA-target recognition. PLoS Biol.2005; 3:e85.
  • 6Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
  • 7Chen CZ, Li L, Lodish HF, Bartel DE MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83- 86.
  • 8Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 9Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16:4-9.
  • 10Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.

共引文献207

同被引文献15

  • 1Wu Z S, Wu Q, Wang C Q, et al. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis [ J ]. BMC Cancer,2010,10 : 542.
  • 2Iorio M V, Ferracin M, Liu C C, et al. MicroRNA gene expres- sion deregulation in human breast cancer[ J]. Cancer Res,2005,65 ( 16 ) :7065 - 70.
  • 3Patryk M, Francesca M B,Yunfeng P, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors[ J]. Mol Cell,2011 ,41 (2) :210-20.
  • 4Rodriguez-Gonzolez F G, Sieuwerts A M, Smid M, et al. MicroR- NA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer[ J]. Breast Cancer Res Treat, 2011,127 ( 1 ) :43 - 51.
  • 5Sun Y, Fang R, Li C, et al. Hsa-mir-182 suppresses lung tumori- genesis through down regulation of RGS17 expression in vitro[ J]. Bioehem Biophys Res Commun,2010,396(2) :501 -7.
  • 6Barshack I, Lithwick-Yanai G, Afek A, et al. MicroRNA expres- sion differentiates between primary lung tumors and metastases to the lung [ J ]. Pathol Res Pract,2010,206 ( 8 ) :578-84.
  • 7Sarver A L, French A J, Borralho P M, et al. Human colon canc- er profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states[ J]. BMC Cancer,2009,9:401.
  • 8Schaefer A, Jung M, Mollenkopf H J, et al. Diagnostic and prog- nostic implications of microRNA profiling in prostate carcinoma [J]. Int J Cancer, 2010,126(5):1166-76.
  • 9Nagaraja A K,Creighton C J,Yu Z,et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer[J]. Mol Endocri- nol,2010,24(2) :447-63.
  • 10Myatt S S, Wang J, Monteiro L J, et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in en- dometrial cancer[ J]. Cancer Res,2010,70( 1 ) :367 -77.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部